5.2.2 Drug Therapeutic Record

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

5.2.

2 Drug Therapeutic Record

Name of General Specific Action Adverse Effects Indication Contraindication Nursing


Drug Action Responsibilities
Clindamyc ANTIBIOTI - Inhibits CNS: headache - Infections caused - Contraindica - Assess patient’s
in C; bacterial CV: by sensitive ted in infection
Anti- protein thrombophlebitis staphylococci, patients before and
ineffective synthesi EENT: pharyngitis streptococci, hypertensive regularly
s by GI: abdominal pneumococci, to drug or throughout
binding pain, anorexia, bacteroides, lincomycin therapy
to 50S bloody or tarry fusibacterium, - Before giving
subunit stools, clostridium first dose,
- Use
of constipation, perfringens, and obtain
ribosom diarrhea, other sensitive cautiously in specimen for
patients
e. dysphagia, aerobic and culture and
esophagitis, anaerobic with renal or sensitivity test,
hepatic
flatulence, organisms. begin therapy
- Hinders nausea, disease, pending results.
or kills asthma,
pseudomembran - Monitor renal,
suscepti ous colitis, - Endocarditis history of GI hepatic, and
ble prophylaxis for disease, or
unpleasant or hematopoetic
bacteria. bitter taste, dental procedures significant functions
in patient’s allergies
vomiting. during
GU: UTI allergic to prolonged
penicillin
HEMATOLOGIC: therapy.
Eosinophilia, - Be alert for
thrombocytopeni adverse
a, transient - Acne vulgaris reactions and
leukopenia - Bacterial drug
SKIN: vaginosis interactions
maculopapular - Pneumocystis - If adverse GI
rash, urticarial jiroveci(carinii) reactions
OTHER: pneumonia occurs, monitor
anaphylaxis, - Toxoplasmosis patient’s
erythema, pain (cerebral or
(I.V. use), ocular) hydration.
induration, pain; immunocomprom - Teach patient
sterile abcess ised patients how to store
(I.M. use) oral solution.
- Tell patient to
take entire
amount
prescribed even
after he feels
better.
- Warn patient
that I.M.
injection may
be painful
- Instruct patient
to report
diarrhea and to
avoid self-
threatening
pseudomembra
nus colitis
- Tell patient
receiving drug
I.V. to report
discomfort at
infusion site.

You might also like